Error: Could not add to watchlist. X

BriaCell Therapeutics Corp

+ Watchlist
ACP:CN
Ticker Change
ACP:CN has changed to a new ticker symbol
CAD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (CAD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
BriaCell Therapeutics Corp. operates as a breast cancer immunotherapy biotech research and developer. The Company developed a patented whole-cell vaccine, cancer immunotherapy technology called the "BriaVax" vaccine. BriaCell has offices in North America.
ADDRESS
Bellevue Center 235
15th Street
Vancouver, BC V7T 2X1
Canada
PHONE
1-604-921-1810
  • Joseph Wagner
    President/CEO
  • Charles L Wiseman
    Chief Medical Officer/Founder
  • Rahoul Sharan
    Chief Financial Officer
  • Senthamil Selvan
    Principal Scientist
  • Steven J O'Day
    Principal Investigator
Show More